Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ JB Hi-Fi H1 Profit Rises (AFX) +++ JB HI-FI Aktie +7,88%

OLYMPUS Aktie

 >OLYMPUS Aktienkurs 
8.871 EUR    (TradegateBSX)
Ask: 8.938 EUR / 560 Stück
Bid: 8.804 EUR / 568 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
OLYMPUS Aktie über LYNX handeln
>OLYMPUS Performance
1 Woche: -5,5%
1 Monat: -10,8%
3 Monate: -12,2%
6 Monate: -2,0%
1 Jahr: -30,2%
laufendes Jahr: -8,8%
>OLYMPUS Aktie
Name:  OLYMPUS CORP.
Land:  Japan
Sektor:  Elektronik / Software
ISIN/ Wkn:  JP3201200007 / 856840
Symbol/ Ticker:  OLY1 (Frankfurt)
Kürzel:  FRA:OLY1, ETR:OLY1, OLY1:GR
Index:  Nikkei225
Webseite:  https://www.olympus-globa..
Profil:  Olympus Corporation is a multinational company known for its advancements in optics, imaging, and medical technology. Originally established in Japan in 1919, Olympus has grown to become a dominant pl..
>Volltext..
Marktkapitalisierung:  11864.93 Mio. EUR
Unternehmenswert:  12088.13 Mio. EUR
Umsatz:  5309.15 Mio. EUR
EBITDA:  1191.3 Mio. EUR
Nettogewinn:  456.06 Mio. EUR
Gewinn je Aktie:  0.41 EUR
Schulden:  1278.6 Mio. EUR
Liquide Mittel:  911.09 Mio. EUR
Operativer Cashflow:  663.97 Mio. EUR
Bargeldquote:  0.49
Umsatzwachstum:  -11.41%
Gewinnwachstum:  -10.42%
Dividende je Aktie:  0.11 EUR
Dividendenrendite:  1.08%
Dividendenschätzung:  1.53%
Div. Historie:  28.03.25 - 0.113952€
28.03.24 - 0.1025568€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  OLYMPUS
Letzte Datenerhebung:  16.02.26
>OLYMPUS Kennzahlen
Aktien/ Unternehmen:
Aktien: 1101.07 Mio. St.
Frei handelbar: 92.51%
Leerverk. Aktien: -
Rückkaufquote: 2.27%
Mitarbeiter: 29297
Umsatz/Mitarb.: 0.19 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 16.2%
Bewertung:
KGV: 23.76
KGV lG: 22.64
KUV: 2.2
KBV: 2.55
PEG-Ratio: 7.24
EV/EBITDA: 10.15
Rentabilität:
Bruttomarge: 66.24%
Gewinnmarge: 8.59%
Operative Marge: 15.56%
Managementeffizenz:
Gesamtkaprendite: 5.92%
Eigenkaprendite: 11.25%
 >OLYMPUS Anleihen 
>OLYMPUS Peer Group
Elektronik / Software, Unterhaltungs- & Computerelektronik
 
16.02.26 - 06:54
Olympus Corp shares slide nearly 14% on FY guidance cut (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
16.02.26 - 06:12
Japan′s Olympus shares fall over 10% as safety issues drag on (Nikkei)
 
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...
16.02.26 - 05:42
Olympus drops after full-year operating income forecast cut (Japan Times)
 
The Japanese medical device maker cut its outlook to between ¥75 billion and ¥87 billion, taking into account progress up to the third quarter....
13.02.26 - 19:25
Earnings call transcript: Olympus senkt Umsatzprognose – Aktie bricht ein (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
13.02.26 - 16:12
Olympus GAAP EPS of ¥12.84, revenue of ¥261.05B (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.02.26 - 08:12
Olympus Corporation Nine Months Income Drops (AFX)
 
TOKYO (dpa-AFX) - Olympus Corporation (OCPNF) released a profit for nine months that Dropped, from the same period last yearThe company's earnings totaled JPY43.357 billion, or JPY38.80 per share.......
28.01.26 - 16:15
Olympus Announces U.S. Launch of the SecureFlex™ Single-Use Fine Needle Biopsy Device (PR Newswire)
 
Olympus' Newest Needle for Endoscopic Ultrasound-Guided Biopsy is Designed to Offer Precision Sampling When Access Matters Most CENTER VALLEY, Pa., Jan. 28, 2026 /PRNewswire/ -- Olympus Corp. of the Americas, a global MedTech company committed to making people's lives healthier, safer and......
15.01.26 - 03:12
Kalamazoo kicks off Mt Olympus pre-feasibility study as Ashburton drilling resumes (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
08.01.26 - 15:18
RQM+ Appoints Ross D. Segan, MD, MBA, FACS, to Board of Directors (Business Wire)
 
Former FDA and Johnson & Johnson leader brings deep clinical, regulatory, and enterprise strategy expertise to “The MedTech CRO.”PITTSBURGH--(BUSINESS WIRE)--#BoardOfDirectors--RQM+, a leading global MedTech service provider (CRO), today announced that Ross D. Segan, M.D., MBA, FACS, has joined its board of directors. Dr. Segan is a physician–executive and MedTech strategist with senior leadership experience at the U.S. Food and Drug Administration (FDA), Johnson & Johnson, Olympus, Covidien, and Vensana Capital, and currently serves as CEO of Medical Scientific Advisors, LLC. “Dr. Segan's leadership at the intersection of clinical practice, regulatory science, and global MedTech innovation is unmatched,” said John Potthoff, Ph.D., chief executive officer of RQM+. “His experience advising regulators, industry leaders, and investors will strengthen RQM+'s ability to help clients navigate complexity and deliver high-impact products to market.” “RQM+'s clear sense of purpose and respect fo...
06.01.26 - 19:39
PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Expanding Ready-To-Use ("RTU") Product Offering in the Hospital Market (PR Newswire)
 
GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid medicines, today announced the acquisition of Nivagen Pharmaceuticals, Inc. ("Nivagen"),......
05.01.26 - 14:09
SageSure Completes Acquisition of Mass-Affluent Homeowners Focused Olympus (Business Wire)
 
Acquisition supports SageSure's Florida growth strategy and mass-affluent focus.JERSEY CITY, N.J.--(BUSINESS WIRE)--SageSure, the largest residential property MGU in the US specializing in catastrophe-exposed markets, announced today that it has completed the acquisition of Gemini Financial Holdings Corporation (“Gemini Financial”) and its Olympus subsidiaries (“Olympus”), one of the leading underwriting franchises in Florida. The transaction was originally announced on September 10, 2025, and closed on January 2, 2026. As part of the transaction, Valence Insurance Holdings, the parent company of SageSure's carrier partners Auros and Interboro Insurance, has acquired Olympus Insurance Company. “SageSure is proud to join forces with Olympus and build on its success in the Florida admitted homeowners market,” said Terrence McLean, President and CEO of SageSure. “This milestone enables our businesses to leverage complementary capabilities and drive growth in the mass affluent homeowners segme...
15.12.25 - 09:36
PRAGMATIC PLAY STRIKES GOLD WITH FORTUNE OF OLYMPUS (PR Newswire)
 
GIBRALTAR, 15th December 2025 /PRNewswire/-- Pragmatic Play, a leading content supplier to the iGaming industry, unleashes a thunderous new entry in its iconic Greek Gods series with Fortune of Olympus – an electrifying 7x7 cluster-pays slot charged with random multipliers, dynamic......
11.12.25 - 02:33
Olympus Partners Announces Promotion (PR Newswire)
 
STAMFORD, Conn., Dec. 10, 2025 /PRNewswire/ -- Olympus Partners is pleased to announce that as of Jan. 1, 2026, Sam Greenberg is promoted to Partner. Sam joined Olympus in 2015 from Lazard & Co. He was promoted to Principal in 2022. He focuses on transactions in the industrial and......
10.12.25 - 15:03
Integrity Growth Partners Announces Oversubscribed $220M Fund, Validating Founder-Focused, Transparent Approach to Private Equity (Business Wire)
 
The firm's first committed capital fund will continue IGP's strategy of investing in growth-stage B2B software and tech-enabled companies LOS ANGELES--(BUSINESS WIRE)--Integrity Growth Partners (“IGP”), a growth‑equity firm focused on founder‑owned, growth‑stage technology companies, today announced the close of its $220 million fund, exceeding its $200 million target. The oversubscribed fund reflects strong confidence and significant commitments from limited partners, including StepStone Group, Oxford Financial Group, Ltd., and Olympus Ventures, among others. IGP blends long-term, value-added partnership with its proprietary data and AI platform to drive rigorous, thesis-driven sourcing and value creation. Prior to raising this fund, the IGP team deployed more than $250 million across six single‑deal investments, emphasizing a transparent, relationship-driven, and founder-led philosophy that reinforced the firm's outlook and strategy. With this additional capital, IGP will continue investi...
05.12.25 - 22:03
Olympus Announces Voluntary Corrective Action for the Single-Use Ligating Device (PR Newswire)
 
CENTER VALLEY, Pa., Dec. 5, 2025 /PRNewswire/ -- Olympus Corporation today announced a voluntary medical device corrective action for its Single-Use Ligating Device ("PolyLoop") following identification of a potential safety issue. The PolyLoop device is designed for use with Olympus......
05.12.25 - 14:03
Olympus, Gore, and ConMed Announce Transition of Commercial Support for the GORE® VIABIL® Biliary Endoprosthesis in the United States (PR Newswire)
 
CENTER VALLEY, Pa., Dec. 5, 2025 /PRNewswire/ -- Olympus Corporation ("Olympus"), W. L. Gore & Associates, Inc. ("Gore"), and ConMed Corporation ("ConMed") jointly announced today the upcoming transition of commercial support and distribution for the GORE® VIABIL® Biliary Endoprosthesis......
02.12.25 - 23:24
With over R1.2bn in sales, Olympus Sandton breaks ground (Moneyweb)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
02.12.25 - 15:03
Swan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer (Business Wire)
 
BOSTON--(BUSINESS WIRE)--Swan EndoSurgical, an emerging leader in flexible endoluminal surgical robotics, today announced the appointment of Erik Todd as its Chief Executive Officer. Erik joins Swan following more than 25 years of leadership at Stryker Corporation, where he most recently served as Vice President and General Manager of the Robotics and Enabling Technologies division. Erik brings deep experience scaling next-generation robotic platforms, building high-performance global engineering organizations, and driving innovation across endoscopy, minimally invasive surgery, and digital/AI-enabled enabling technologies. Swan EndoSurgical is backed by Revival Healthcare Capital and Olympus Corporation and is focused on delivering a fully integrated flexible endoluminal robotic platform for complex gastrointestinal interventions. “Erik is an accomplished and respected leader in surgical robotics,” said Justin Ballotta, Managing Director at Revival Healthcare Capital and Head of Post-Investment Value...
17.11.25 - 10:30
Spinomenal Unveils Mega Zeus Hold & Hit 3x3 (Cision)
 
Leading iGaming content provider Spinomenal has expanded its successful Mythology series with the launch of Mega Zeus Hold & Hit 3x3. Set among the golden columns of Mount Olympus, Mega Zeus transports players to the realm of the mighty god of thunder. With Zeus himself sitting high above the reels, every spin ripples with energy and anticipation, carrying the potential for electrifying wins. The temple of the gods acts as the Wild symbol and substitutes for all symbols except the Bonus and Bonus Collect. Mega Zeus Hold & Hit 3x3 has two Special Bonus symbols, the Bonus only lands on...
12.11.25 - 20:03
IWG Acquires EMS Elektro Metall Schwanenmühle (PR Newswire)
 
STAMFORD, Conn., Nov. 12, 2025 /PRNewswire/ -- International Wire Group (IWG), an Olympus Partners portfolio company, has acquired EMS Elektro Metall Schwanenmühle GmbH (EMS). Based in Horbach, Germany, and with operations in Orozkow, Poland, EMS is a market leading supplier for......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Auf Kontinuität setzen vor allem die, denen noch nie etwas Neues eingefallen ist. - Dr. Fritz P. Rinnhofer
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!